ARMANDI, Angelo

ARMANDI, Angelo  

SCIENZE MEDICHE  

Mostra records
Risultati 1 - 20 di 75 (tempo di esecuzione: 0.029 secondi).
Titolo Data di pubblicazione Autore(i) File
A nutrigenetic precision approach for the management of non-alcoholic fatty liver disease 2023 Nuria Perez-Diaz-Del-Campo, Eleonora Dileo, Gabriele Castelnuovo, Aurora Nicolosi, Marta Guariglia, Gian Paolo Caviglia, Chiara Rosso, Angelo Armandi, Elisabetta Bugianesi
A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy 2021 Ribaldone, DG; Zurlo, C; Fagoonee, S; Rosso, C; Armandi, A; Caviglia, GP; Saracco, GM; Pellicano, R
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals 2022 Saponaro, Chiara; Sabatini, Silvia; Gaggini, Melania; Carli, Fabrizia; Rosso, Chiara; Positano, Vincenzo; Armandi, Angelo; Caviglia, Gian Paolo; Faletti, Riccardo; Bugianesi, Elisabetta; Gastaldelli, Amalia
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology 2020 Caviglia, Gian Paolo; Ciruolo, Michela; Abate, Maria Lorena; Carucci, Patrizia; Rolle, Emanuela; Rosso, Chiara; Olivero, Antonella; Troshina, Giulia; Risso, Alessandra; Nicolosi, Aurora; Ribaldone, Davide Giuseppe; Armandi, Angelo; Tandoi, Francesco; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Ciancio, Alessia; Gaia, Silvia
Analytical and clinical comparison between two different chemiluminescent enzyme immunoassays for the measurement of C-peptide in serum 2021 Gian Paolo Caviglia, Chiara Rosso, Angelo Armandi, Davide Giuseppe Ribaldone, Rinaldo Pellicano, Elisabetta Bugianesi
Association Between Gut Permeability and Insulin Resistance: Any Role for Zonulin in Patients with Non-Alcoholic Fatty Liver Disease? 2021 Chiara Rosso, Gian Paolo Caviglia, Angelo Armandi, Davide Giuseppe Ribaldone, Elisabetta Bugianesi
Beyond the paradigm of weight loss in non‐alcoholic fatty liver disease: From pathophysiology to novel dietary approaches 2021 Armandi A.; Schattenberg J.M.
Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 2021 Caviglia G.P.; Armandi A.; Rosso C.; Gaia S.; Aneli S.; Rolle E.; Abate M.L.; Olivero A.; Nicolosi A.; Guariglia M.; Ribaldone D.G.; Carucci P.; Saracco G.M.; Bugianesi E.
Can Periodontitis Affect the Health and Disease of the Digestive System? A Comprehensive Review of Epidemiological Evidence and Biological Mechanisms 2021 Baima G.; Ribaldone D.G.; Muwalla M.; Romano F.; Citterio F.; Armandi A.; Aimetti M.
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? 2022 Younes, Ramy; Govaere, Olivier; Petta, Salvatore; Miele, Luca; Tiniakos, Dina; Burt, Alastair; David, Ezio; Vecchio, Fabio Maria; Maggioni, Marco; Cabibi, Daniela; McLeod, Duncan; Pareja, Maria Jesus; Fracanzani, Anna Ludovica; Aller, Rocio; Rosso, Chiara; Ampuero, Javier; Gallego-Durán, Rocío; Armandi, Angelo; Caviglia, Gian Paolo; Zaki, Marco Y W; Liguori, Antonio; Francione, Paolo; Pennisi, Grazia; Grieco, Antonio; Birolo, Giovanni; Fariselli, Piero; Eslam, Mohammed; Valenti, Luca; George, Jacob; Romero-Gómez, Manuel; Anstee, Quentin Mark; Bugianesi, Elisabetta
Changes in Liver Stiffness and Markers of Liver Synthesis and Portal Hypertension Following Hepatitis C Virus Eradication in Cirrhotic Individuals 2022 Angelo Armandi, Chiara Rosso, Giulia Troshina, Nuria Perez Diaz Del Campo, Chiara Marinoni, Aurora Nicolosi, Gian Paolo Caviglia, Giorgio Maria Saracco, Elisabetta Bugianesi, Alessia Ciancio
Chronic Intestinal Disorders in Humans and Pets: Current Management and the Potential of Nutraceutical Antioxidants as Alternatives 2022 Meineri G.; Martello E.; Radice E.; Bruni N.; Saettone V.; Atuahene D.; Armandi A.; Testa G.; Ribaldone D.G.
Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification 2022 Olivero A.; Rosso C.; Ciancio A.; Abate M.L.; Nicolosi A.; Troshina G.; Armandi A.; Ribaldone D.G.; Saracco G.M.; Bugianesi E.; Rizzetto M.; Caviglia G.P.
Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification. 2022 Olivero A, Rosso C, Ciancio A, Abate ML, Nicolosi A, Troshina G, Armandi A, Ribaldone DG, Saracco GM, Bugianesi E, Rizzetto M, Caviglia GP.
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy 2018 Shahini, Endrit; Iannone, Andrea; Romagno, Domenico; Armandi, Angelo; Carparelli, Sonia; Principi, Mariabeatrice; Viggiani, Maria Teresa; Ierardi, Enzo; Di Leo, Alfredo; Barone, Michele
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report 2020 Caviglia, Gian Paolo; Tucci, Alessandra; Pellicano, Rinaldo; Fagoonee, Sharmila; Rosso, Chiara; Abate, Maria Lorena; Olivero, Antonella; Armandi, Angelo; Vanni, Ester; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Astegiano, Marco; Ribaldone, Davide Giuseppe
Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn’s Disease 2024 Cusato, Jessica; Cafasso, Carla; Antonucci, Miriam; Palermiti, Alice; Manca, Alessandra; Caviglia, Gian Paolo; Vernero, Marta; Armandi, Angelo; Saracco, Giorgio Maria; D’Avolio, Antonio; Ribaldone, Davide Giuseppe
Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease 2023 Armandi, Angelo; Rosso, Chiara; Younes, Ramy; Leeming, Diana Julie; Karsdal, Morten A; Caviglia, Gian Paolo; Pérez-Diaz-Del-Campo, Nuria; D'Amato, Daphne; Abdulle, Amina; Nicolosi, Aurora; Castelnuovo, Gabriele; Saracco, Giorgio Maria; Ribaldone, Davide Giuseppe; Bugianesi, Elisabetta
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease 2022 Armandi A.; Rosso C.; Nicolosi A.; Caviglia G.P.; Abate M.L.; Olivero A.; D'amato D.; Vernero M.; Gaggini M.; Saracco G.M.; Ribaldone D.G.; Leeming D.J.; Gastaldelli A.; Bugianesi E.
Derivation and validation of the NAFLD Cirrhosis Score (NCS) to distinguish bridging fibrosis from cirrhosis 2022 Labenz C, Toenges G, Zheng M, Ding D, Myers RP, Galle PR, Armandi A, Ampuero J, Romero Gomez M, Bugianesi E, Anstee QM, Schattenberg JM